Literature DB >> 2838969

Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter.

T Kanda1, S Watanabe, K Yoshiike.   

Abstract

We tested the human papillomavirus 16 (HPV 16) early genes for their ability to immortalize or transform primary rat brain cells, using the expression plasmids that contain the neomycin-resistance-inducing unit (pSV2neo) and the transcriptional unit for the HPV 16 subgenomic DNA fragments controlled by the SV40 early promoter. After transfection, drug-resistant colonies were maintained by refeeding and replating for characterization. The E7 gene alone was found to be capable of immortalizing and morphologically transforming primary rat cells, and the transformed cells showed anchorage-independent growth. Although its activity was lower than that of the E7 gene, the E6 gene also immortalized primary rat cells. The immortalized or transformed cells contained HPV 16-specific DNA and mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838969     DOI: 10.1016/0042-6822(88)90694-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.

Authors:  W C Phelps; K Münger; C L Yee; J A Barnes; P M Howley
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

Authors:  A Larose; N Dyson; M Sullivan; E Harlow; M Bastin
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Reconstruction of liver organoid using a bioreactor.

Authors:  Masaya Saito; Tomokazu Matsuura; Takahiro Masaki; Haruka Maehashi; Keiko Shimizu; Yoshiaki Hataba; Tohru Iwahori; Tetsuro Suzuki; Filip Braet
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

4.  In vitro expressed HPV 8 E6 protein does not bind p53.

Authors:  G Steger; H Pfister
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

Authors:  M Scheffner; K Münger; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences.

Authors:  K Münger; C L Yee; W C Phelps; J A Pietenpol; H L Moses; P M Howley
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism.

Authors:  W C Phelps; S Bagchi; J A Barnes; P Raychaudhuri; V Kraus; K Münger; P M Howley; J R Nevins
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors.

Authors:  P Auewarakul; L Gissmann; A Cid-Arregui
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.

Authors:  M C McIntyre; M G Frattini; S R Grossman; L A Laimins
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.